Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCM Intervention for Diabetes Prevention in Psoriasis
NCT06402760Phase 1Not yet recruiting
- Sponsor
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
- Start
- Jul 2024
- Primary completion
- Oct 2025
- Modality
- HM (Herbal Medicine)
01
Overview
Phase 1, open-label trial of Taodan granules in psoriasis and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. Primary endpoints: Glycated Hemoglobin at Week 40, Fasting Plasma Glucose at Week 40 and 4 more. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
Taodan granules
03
Conditions
psoriasistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06402760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06402760.